Invinity Energy Systems' (IES) Buy Rating Reaffirmed at Canaccord Genuity Group

Key Points

• Analysts at Canaccord Genuity Group have reaffirmed a "buy" rating for Invinity Energy Systems (IES), setting a price target of GBX 40, indicating a potential upside of 71.84% from the current stock price.
• IES stock currently trades at GBX 23.28, with a 52-week range between GBX 7.76 and GBX 29, signifying significant volatility.
• Invinity Energy Systems specializes in manufacturing vanadium flow batteries, having deployed systems in 82 sites across 15 countries, positioning them as a leader in the energy storage sector.

Invinity Energy Systems (LON:IES - Get Free Report)'s stock had its "buy" rating reissued by analysts at Canaccord Genuity Group in a note issued to investors on Tuesday,Digital Look reports. They presently have a GBX 40 price objective on the stock. Canaccord Genuity Group's price target points to a potential upside of 71.84% from the company's current price.

Invinity Energy Systems Price Performance

IES stock opened at GBX 23.28 on Tuesday. Invinity Energy Systems has a 52-week low of GBX 7.76 and a 52-week high of GBX 29. The stock's fifty day simple moving average is GBX 21.68 and its 200-day simple moving average is GBX 17.74. The company has a quick ratio of 2.00, a current ratio of 6.96 and a debt-to-equity ratio of 0.87. The stock has a market capitalization of £102.55 million, a price-to-earnings ratio of -347.43 and a beta of 2.24.

Invinity Energy Systems Company Profile

Invinity Energy Systems plc is a global manufacturer of vanadium flow batteries (VFB), a leading alternative to lithium-ion technology. Ideally placed to address the substantial demand for long-duration utility-grade stationary energy storage solutions, Invinity has deployed its modular battery systems across 82 sites in 15 countries, more than any other company in the space.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.